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Disc tissue is adaptable to loading and this adaptation re-
sults in consequent disc remodeling. It has been reported that 
articular disc and bony changes are related to various kinds 
of extracellular matrix and expression of certain enzymes1. 
Matrix metalloproteinase (MMP) affects progress of TMJ 
disorders and also serves as a crucial indicator of early stage 
degenerative joint changes. It has been demonstrated that 
MMPs and their inhibitors are involved in both physiologi-
cal and pathological conditions in rabbit study2. In human 
studies, MMP-1, 2, 3, 9, and 13 have been detected in the sy-
novial fluid of osteoarthritis (OA) patients3-6, and expression 
and concentration of MMP-2, 3, and 9 increased in synovial 
fluid of patients with internal derangement (ID) or OA4,7. 
Therefore, it can be suggested that upregulation of MMP-1, 
2, 3, 8, 9, and 13 in the synovial fluid from TMJ ID or in OA 
patients means pathological degradation and destruction of 
TMJ tissue8. 
The MMP family contains the only mammalian proteinases 
I. Introduction
Discrepancies between clinical symptoms, radiographic 
findings, and operative findings for temporomandibular joint 
(TMJ) disorders sometimes confuse clinicians. For this rea-
son, many studies have tried to discover markers of TMJ dis-
orders with resected tissue or molecules in synovial fluid and 
cartilage to make accurate diagnoses. 
ORIGINAL ARTICLE
Jong-Ki Huh
Department of Oral and Maxillofacial Surgery, Gangnam Severance 
Hospital, Yonsei University College of Dentistry, 211 Eonju-ro, Gangnam-
gu, Seoul 06273, Korea
TEL: +82-2-2019-4560   FAX: +82-2-3463-4052
E-mail: omshuh@yuhs.ac
ORCID: https://orcid.org/0000-0002-7381-3972
   This is an open-access article distributed under the terms of the Creative 
Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
CC
Expression of collagenases (matrix metalloproteinase-1, 8, 13) 
and tissue inhibitor of metalloproteinase-1 of retrodiscal tissue in 
temporomandibular joint disorder patients
Won Gyung Gho1, Yuri Choi2, Kwang-Ho Park2, Jong-Ki Huh2
1Department of Dentistry, Myongji Hospital, Goyang,  
2Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry, Seoul, Korea
Abstract (J Korean Assoc Oral Maxillofac Surg 2018;44:120-127)
Objectives: The aim of this study was to reveal how collagenases (matrix metalloproteinase [MMP]-1, 8, 13) and tissue inhibitor of metalloproteinase 
1 (TIMP-1) are expressed in immunohistochemistry of retrodiscal tissue in temporomandibular joint disorder patients. 
Materials and Methods: This study was conducted on 39 patients who underwent discoplasty or discectomy. Immunohistochemical staining was 
undertaken and expression levels of MMP-1, 8, 13, and TIMP-1 were evaluated. The status of internal derangement of disc, osteoarthritis, and joint ef-
fusion were analyzed using magnetic resonance imaging (MRI). Disc status observed during operation was also categorized. 
Results: The more severe disc derangement was observed on MRI, the more increased expression of MMPs and TIMP-1 appeared. Regarding MMP-
13 expression, 86.7% of late-stage disc displacement patients showed grade II or III. Expression level of MMPs or TIMP was not statistically signifi-
cant associated with joint effusion level. In perforation and/or adhesion groups, all patients showed grade II or III expression of MMP-13. Once perfo-
ration occurred, MMP-13 showed increased expression with statistical significance.
Conclusion: MMP-1 and MMP-13 expression seem to be related to progression of osteoarthritis whereas MMP-8 does not seem to have a specific 
role with regard to temporomandibular joint disorders. TIMP-1 is considered to be partly related to internal derangement rather than osteoarthritis, but 
it is not significant.
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cam, Cambridge, UK) and MMP-8 antibody (EP1252Y; Ab-
cam) were rabbit monoclonal to origins with synthetic pep-
tide corresponding to residues in human MMP-1 or MMP-8. 
MMP-13 antibody (Abcam) was a rabbit polyclonal to MMP-
13 human recombinant MMP-13 protein. TIMP-1 antibody 
(102D1; Abcam) was a mouse monoclonal origin from which 
BALB/C mice injected with recombinant human TIMP-1.
After washing in TBS, sections were incubated with a 
biotinylated secondary antibody for ten minutes at room 
temperature and rinsed. Then, they were rewashed after ten 
minutes of incubation with streptavidin-peroxidase at room 
temperature. In the above process, Histostain-plus kit (Zymed, 
Camarillo, CA, USA) was used. Finally they were colorized 
by diaminobenzidine tetrahydrochloride (DAB), counter-
stained with Meyer’s hematoxylin, and sealed with glycerol.
2) Evaluation of immunohistochemical staining
Staining patterns were classified into three grades according 
to expression levels of MMP-1, 8, 13 and TIMP-1. Those with 
diffuse expression less than 20 cells were classified as grade I; 
multiple group expression from 20 to 100 cells, grade II; and 
positive expression more than 100 cells, grade III.(Fig. 1)
3) Analysis of magnetic resonance imaging findings
MRI findings for ID were classified into four groups—nor-
mal position, disc displacement with reduction (DDcR), early 
stage of disc displacement without reduction (EDDsR), and 
late stage of disc displacement without reduction (LDDsR), 
based upon the position and status of joint disc on T-1 
weighted MRI9.
(1) Normal: The disc is biconcave with the posterior band 
lying over the condyle, and the central thin zone is located 
between the condyle and the posterior part of the articular 
eminence.
(2) DDcR: When the jaw closes, the disc displaces ante-
riorly, anterolaterally, or anteromedially. But when the jaw 
opens, the disc is reduced to normal position.
(3) EDDsR: The disc displaced relative to the condylar 
head, regardless of jaw position. Disc slightly thickens at its 
posterior edge or begins to be deformed anatomically. When 
the jaw closes, the disc displaces slightly forward. When the 
jaw opens, disc deformity is observed.
(4) LDDsR: The disc displacement is similar to EDDsR, 
and also significant anatomical disc deformity is seen such 
as spectacles shape or amorphous form. When the jaw opens, 
the disc follows anterior movement of the condyle without 
anatomical deformity.
known as ‘collagenases’. The ‘classical’ collagenases-1, 2, 
and 3 (MMP-1, 8, 13) are specific for certain collagens. Col-
lagenases can affect matrix changes in the retrodiscal tissue 
which is composed of collagen type I and II. Meanwhile, 
activated MMPs are mainly regulated by tissue inhibitor of 
metalloproteinase (TIMP), classified as TIMP-1, 2, 3, and 4. 
Among TIMPs, TIMP-1 resists collagenase, stromelysin, and 
gelatinase. 
The retrodiscal tissue from TMJ disorder patients who 
underwent TMJ surgery usually shows fibrous degeneration, 
congestion, adhesion, or perforation. But because of difficul-
ties in subject selection, current studies are insufficient to 
find out extracellular matrix-related factors for these changes. 
Therefore in this study, MMP-1, 8, 13 and TIMP-1 expres-
sion were investigated from retrodiscal tissue sections ob-
tained during TMJ open surgery. To understand the relation-
ship between expression of these enzymes and TMJ structural 
changes, immunohistochemical findings, magnetic resonance 
imaging (MRI), and operative findings were analyzed.
II. Materials and Methods
1. Materials
This study was conducted on 39 TMJs of 39 patients who 
had undergone discoplasty or discectomy. Patients were di-
agnosed as ID or OA based upon clinical examination and 
MRI at the Department of Oral and Maxillofacial Surgery at 
Gangnam Severance Hospital (Seoul, Korea).
The wedge-shaped sample was obtained from the lateral 
side of retrodiscal tissue during discoplasty. During discec-
tomy, tissue samples were obtained from both articular disc 
and retrodiscal tissue.
2. Methods
1) Immunohistochemistry
Each 5 µm-thick tissue section, which had been fixed in 
10% neutral-buffered formalin and embedded in paraffin, was 
placed on a silanized slide. Sections were deparaffinized with 
xylene and soaked in ethanol. The sections were incubated in 
3% hydrogen peroxide for 10 minutes to quench endogenous 
peroxidase activity and washed with Tris-buffered saline 
(TBS). After blocking the binding of nonspecific protein us-
ing serum blocking solution for ten minutes, sections were 
incubated with a primary antibody, diluted 1:50, for an hour 
at room temperature. Each MMP-1 antibody (EP1247Y; Ab-
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teophytosis, resorption bone marrow signal change
• Temporal bone: generalized sclerosis and flattening, ir-
regular bony surface
• Shortening in ramal length or no change in ramal length
MRI findings for joint effusion were classified into level 0, 
1, 2, or 3 based upon the amount of fluid collection or signal 
intensity on T-2 weighted MRI9.
(1) Level 0: No evidence of high signal intensity in the 
joint space
(2) Level 1: Fluid collection is seen in the boundary of tem-
poral bone and disc or high signal intensity is visible within 
the folded disc
(3) Level 2: High signal intensity is visible in the anterior 
recess of upper or lower joint space. It extends outside the 
boundary of the disc
(4) Level 3: High signal intensity is seen in the whole re-
gion of the upper or lower joint space
The diagnosis of degenerative joint depended on whether a 
patient has OA which includes erosion of mandibular condyle 
or condylar fossa, sclerosis, or absorption of cortical bone 
and signal change of bone marrow. The diagnostic criteria of 
OA on MRI are as follows:
(1) Normal bony structure 
• No abnormal cortical bony changes such as flattening, 
sclerosis, spurring, osteophytosis and erosion in the condylar 
head and temporal part of joint.
• No abnormal bone marrow signal change of the condyle
(2) Mild stage of OA 
• Condylar head: localized cortical erosion or sclerosis, 
bony spurring without evidence of bone marrow signal 
change
• Temporal bone: localized cortical erosion or sclerosis
• No change in ramal length
(3) Severe stage of OA
• Condylar head: generalized flattening and sclerosis, os-
Fig. 1. Immunohistochemistry. A, B. 
Grade I expression, with extremely 
small portions of retrodiscal tissue re-
moved after discoplasty was colorized 
(A: ×200, B: ×400). C, D. Grade II ex-
pression, with higher numbers of posi-
tive tissue cells and clearer expression 
than grade I (C: ×200, D: ×400). E, F. 
Grade III expression, with even expres-
sion in cytoplasm and broad staining (E: 
×200, F: ×400).
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4) Analysis of operative findings
The patients were categorized into four groups. The first 
group showed no signs of adhesion or perforation. The sec-
ond group showed partial or entire adhesion of the articular 
disc or the retrodiscal tissue to the condylar eminence or 
fossa. The third group showed perforation with upper joint 
cavity connected to the lower joint cavity. The fourth group 
showed both adhesion and perforation.
5) Statistical analysis
Data analysis was performed by chi-square test and Fish-
er’s exact test of cross tabulation analysis using IBM SPSS 
Statistics ver. 12.0 for Windows (SPSS Inc., Chicago, IL, 
USA).
This study was conducted with approval from the Institu-
tional Review Board at Yonsei University Gangnam Sever-
ance Hospital (IRB no. 3-2015-0076) and in compliance with 
the Declaration of Helsinki.
III. Results
Three males (7.7%) and 36 females (92.3%) were included 
in the present study with the average of age 33 years (range, 
21-70 years). Twenty-eight patients underwent discoplasty 
while the other 11 underwent discectomy. The expression 
levels of MMPs and TIMP-1 are shown in Table 1. MMP-
1 and MMP-8 were expressed in all cases, and 64% of cases 
showed grade I expression. MMP-13 was expressed in all 
cases; however, 44% and 41% of cases showed grade II and 
III expression.
1. Comparison with MRI findings
Normal positioned disc was absent in this study and 2, 7, 
and 30 joints were diagnosed as DDcR, EDDsR, and LDDsR 
respectively based on MRI. In MMP-13 expression, 86.7% of 
the LDDsR group showed grade II or III. With more severe 
disc derangement status, more frequent MMPs and TIMP-1 
expression was observed.(Table 1)
With regard to OA, 5, 28, and 6 joints were categorized as 
normal, mild, and severe stage respectively. Interestingly, in 
mild and severe OA stages MMP-13 grade II and III showed 
higher percentages. But among mild stage patients, grade I 
were dominant in other MMPs and TIMP-1.(Table 1)
In joint effusion, 11 cases were level 0, 16 cases were level 
1, and 10 cases were level 2. Level 3 was not found in this 
research. There was not statistical significance in comparison Ta
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and the state of TMJ such as ID, OA, adhesion or perforation 
of disc.
Collagenase-1 (MMP-1) is produced and immediately se-
creted from some mesenchymal cells in response to specific 
inducers12,13. In contrast, collagenase-2 (MMP-8) is primar-
ily produced by neutrophils during their maturation in bone 
marrow, and it is then stored until the cells are stimulated to 
degranulate12,13. Collagenase-3 (MMP-13) is found in bone, 
normal and pathologic cartilage, and various epithelial can-
cers, and it is the predominant collagenase in mice and rats 
while collagenase-1 is undetectable in these species13-16. Al-
though each mammalian collagenase can degrade all fibrillar 
collagens, the preferred substrates for collagenases 1, 2 and 
3 are collagens type III, I and II respectively17,18. Gepstein et 
al.19 reported it has been established that although individual 
enzymes have similar substrate specificities, their expression 
pattern is often distinct and characteristic in a certain tissue 
and cell type. In this study, all cases showed MMP-1, 8, 13 
and TIMP-1 expression but the range or cell type of expres-
sion were different. MMP-13, so-called ‘osteoblast collage-
nase’, demonstrated high expression grade generally. With 
more expression of MMP-13, there was more degenerative 
ID or OA extent. This could verify the importance of collagen 
type II in retrodiscal tissue as well as articular cartilage of 
TMJ. As specificity of collagenases, MMP-1 called ‘fibroblast 
collagenase’ was expressed on fibroblast and MMP-8 called 
‘neutrophil collagenase’ was expressed on neutrophils. The 
expression site and level of each collagenase showed diver-
sity. 
Some conflicting results could be explained partially by 
differences in the sensitivity of the assays used for detect-
ing MMPs and TIMPs such as immunohistochemistry, in 
situ hybridization, zymography, western blots, and northern 
blots. One study reported that different results can be related 
to detected location of MMPs that isolated chondrocytes, sy-
novial fluids, cultured explants, or intact cartilages20. Huh et 
al.21 reported that they found MMP-1 mRNA from seven out 
of eight joints with OA and suggested that MMP-1 from ret-
rodiscal tissue can play a role in destruction of cartilage and 
bone structure in TMJ. Another study showed that MMP-1 
is active in synovial fluid of patients with pain in most cases 
and that a high concentration of MMP-1 can increase joint 
inflammation22. As mentioned above, the role of MMP-1 is 
not yet clear; however, it can be suggested that MMP-1 is in-
volved in disc displacement or other related diseases because 
collagen is a major component of the retrodiscal tissue. In 
this study, 5/6 cases in the severe OA group expressed grade 
between expression of MMPs or TIMP and joint effusion 
level.(Table 1)
2. Comparison with operative findings
In 13 cases, adhesion and perforation was not found. In 17 
cases, only perforation was observed and in 10 cases both ad-
hesion and perforation were observed. There were no cases of 
only adhesion in this research. In perforation and/or adhesion 
groups, all patients showed grade II or III MMP-13 expres-
sion. Once perforation occurred, expression of MMP-13 was 
increased with statistical significance.(Table 1)
IV. Discussion
MMP is an endogenous proteinase whose activity depends 
on Zn2. It plays an important role in degeneration of all kinds 
of collagen, proteoglycan, extracellular matrix, and particu-
larly cartilage. It also contributes to breakdown of basement 
membrane and metabolism of normal matrix tissue10. MMPs 
are classified by their function into five groups including in-
terstitial collagenases (MMP-1, 8, 13), gelatinases (MMP-2, 
9), stromelysins (MMP-3, 10), membrane-type MMPs, and 
other MMPs.
Activated MMPs can be inhibited by a common proteinase 
inhibitor such as α2-macroglobulin, but are mainly inhibited 
by TIMPs as the chief endogenous MMP regulator, classified 
as TIMP-1, 2, 3, and 4. Among them, TIMP-1 is produced by 
most connective tissue cells and macrophages, and it resists 
against collagenase, stromelysin, and gelatinase.
The combination of extracellular matrix, including colla-
gen, relieves pressure and tensile force put on joints. Howev-
er, once these forces start to hurt articular cells, various kinds 
of degenerative enzymes are secreted and degrade connective 
tissue. Thus, to detecting TMJ disorders, some studies on 
synovial fluid have been conducted with the hypothesis that 
damaged extracellular matrix and degenerative enzymes will 
be released into the synovial fluid in TMJ disorder patients. 
These studies already have suggested involvement of MMPs 
in TMJ disease by increased MMP-13 levels in synovial 
fluid from patients with ID11. Since most human studies have 
been carried out using synovial fluid, the production site of 
these enzymes has never been investigated in degenerated 
disc tissue. The purpose of this study was to identify MMPs 
and TIMP-1 immunoreactive patterns with retrodiscal tissue 
samples obtained during surgery. This study also evaluated 
the association between these enzymes from retrodiscal tissue 
Expression of collagenases (MMP-1, 8, 13) and tissue inhibitor of TIMP-1 of retrodiscal tissue in TMD patients
125
been reported that there is a correlation between the concen-
tration of TIMP-1 and MMP-1, and the imbalance between 
them in the progression of OA results in unrecoverable deg-
radation of cartilage matrix26. During OA, the production of 
TIMP-1 is correlated to the level of MMPs. Their imbalance 
in the progression of OA may lead to the destruction of car-
tilage27. Whereas overexpression of collagenage-1, coupled 
with decreased production of TIMP-1, may impair healing, 
insufficient proteinase activity may lead to accumulation 
of wound-associated tissue and delays in wound closure. 
Thus, the properly regulated, site-specific expression of col-
lagenase, as well as other MMPs, may be needed to promote 
efficient wound repair13. This study shows lower expression 
of TIMP-1 than MMPs, because it might be that the experi-
mental groups were patients with TMJ disorder. Four cases 
of grade III expression of TIMP-1 was applied to LDDsR 
and mild or severe stage of OA. TIMP-1 expression seemed 
to affect ID in comparison with OA results, but it was not 
significant. Nevertheless our study assumes that TIMP-1 can 
be active if MMP expression pattern fits into grade II or III 
without any change or destruction in joint structures.
The imbalance between MMP-1 and TIMP-1 also plays 
an important role in the degradation of extracellular matrix28. 
This imbalance and reduced expression of TIMP-1, which 
suppresses the degradation of extracellular matrix, can ex-
plain aggressive patterns against bone or cartilage. Follow-up 
surveys on OA-related symptoms among TMJ disorder, in-
cluding interactions of MMP-1, 13 and TIMP-1, are required 
for clinical applications.
This study was aimed to observe how collagenases (MMP-
1, 8, 13) and TIMP-1 are expressed in immunohistochemistry 
of retrodiscal tissue sections in order to understand how their 
expression pattern is associated with ID, OA, joint effusion, 
and adhesion or perforation among TMJ disorder patients.
V. Conclusion
In conclusion, MMP-13 plays a critical role in degrading 
of OA as it is the predominant collagenase in collagen type 
II and can worsen ID as the collage breakdown enzyme of 
retrodiscal tissue in TMJ. MMP-1 is related to degeneration 
of OA. MMP-8 does not characterize specificity with regard 
to TMJ disorder. TIMP-1 seems to affect ID in comparison 
with OA expression, but it is not significant. In this study, the 
causal relation of the imbalance between MMP and TIMP 
could not be explained, but TIMP activity, which shows a 
difference with degeneration of TMJ disorders, suggests that 
II and III MMP-1 expression and it also suggested that MMP-
1 is associated with destruction of bone and cartilage of TMJ 
even with the small experimental group. But the character of 
MMP-8 expression was unclear in comparison with ID, OA, 
and surgical findings.
Among MMPs, MMP-13 (collagenase-3) appears to play a 
key role in joint connective tissue remodeling. MMP-13 can 
cleave type II collagen 10 times faster than MMP-1. MMP-13 
expression has also been demonstrated in articular cartilage in 
OA patients and in synovium of rheumatoid arthritis patients. 
In this study, control disc cells were rarely immunopositive 
for MMP-13, although a few scattered fibroblast-like cells 
showed faint positive immunoreactions. MMP-13 was upreg-
ulated in TMJ disc tissue from IDs patients. One study also 
reported that MMP-13 immunolabelling increased with TMJ 
disc degeneration. Thus MMP-13 has been thought to play an 
active role in the synthesis of ECM-degrading proteinases23. 
In this study, with more MMP-13 in retrodiscal tissue, there 
was more degenerative ID or OA. The particularly severe OA 
group showed clear expression as grade II or III and this can 
explain that MMP-13 as well as MMP-1 is related with OA 
of TMJ. In comparison of MMP-13 expression with the posi-
tion and status of articular disc, 86.7% of a group of LDDsR 
showed grade II or III, which means that breakdown enzymes 
involved in articular disc degeneration become more active 
as ID progresses. The case of grade III expression with DDsR 
in MRI was an OA patient who went through discectomy due 
to severe adhesion and perforation of articular disc.
Marchetti et al.’s study24 demonstrated that structural modi-
fications of articular disc could be specific responses to func-
tional change of TMJ and variations in extrinsic stimuli may 
activate intrinsic factors, such as MMPs, that induce struc-
tural modifications in discal tissue. The examination found 
that only the areas with myxoid change or hyalinization were 
stained or these areas resulted in much more staining than 
others, and that cell numbers increased in areas with myxoid 
change. Such differences appeared when the retrodiscal tissue 
deteriorated or responded to passed-on loading caused by ar-
ticular disc displacement, which suggests an association with 
MMPs.
In normal physiological processes, MMP activity is con-
trolled at several levels. Loss of control of MMP activity 
appears to have serious consequences, and aberrations in 
MMP expression have been associated with several diseases. 
Though there is no general awareness of the expression of 
TIMP-1 in osteoarthritic cartilage and synovium, it is thought 
that TIMP-1 correlates with the production of MMPs25. It has 
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TIMP should be considered in potential criteria for preven-
tion of progressive disease via controlling collagenases.
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